Abstract:OBJECTIVE. Confronting the new coronavirus infection known as coronavirus disease 2019 (COVID-19) is challenging and requires excluding patients with suspected COVID-19 who actually have other diseases. The purpose of this study was to assess the clinical features and CT manifestations of COVID-19 by comparing patients with COVID-19 pneumonia with patients with non-COVID-19 pneumonia who presented at a fever observation department in Shanghai, China. MATERIALS AND METHODS. Patients were retrospectively enrolled in the study from January 19 through February 6, 2020. All patients underwent real-time reverse transcription-polymerase chain reaction (RT-PCR) testing. RESULTS. Eleven patients had RT-PCR test results that were positive for severe acute respiratory syndrome coronavirus 2, whereas 22 patients had negative results. No statistical difference in clinical features was observed (p > 0.05), with the exception of leukocyte and platelet counts (p < 0.05). The mean (± SD) interval between onset of symptoms and admission to the fever observation department was 4.40 ± 2.00 and 5.52 ± 4.00 days for patients with positive and negative RT-PCR test results, respectively. The frequency of opacifications in patients with positive results and patients with negative results, respectively, was as follows: ground-glass opacities (GGOs), 100.0% versus 90.9%; mixed GGO, 63.6% versus 72.7%; and consolidation, 54.5% versus 77.3%. In patients with positive RT-PCR results, GGOs were the most commonly observed opacification (seen in 100.0% of patients) and were predominantly located in the peripheral zone (100.0% of patients), compared with patients with negative results (31.8%) (p = 0.05). The median number of affected lung lobes and segments was higher in patients with positive RT-PCR results than in those with negative RT-PCR results (five vs 3.5 affected lobes and 15 vs nine affected segments; p < 0.05). Although the air bronchogram reticular pattern was more frequently seen in patients with positive results, centrilobular nodules were less frequently seen in patients with positive results. CONCLUSION. At the point during the COVID-19 outbreak when this study was performed, imaging patterns of multifocal, peripheral, pure GGO, mixed GGO, or consolidation with slight predominance in the lower lung and findings of more extensive GGO than consolidation on chest CT scans obtained during the first week of illness were considered findings highly suspicious of COVID-19.

Computed Tomography and Clinical Features Differentiating Coronavirus Disease 2019 from Seasonal Influenza Pneumonia

Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia

Comparison of the Clinical and CT Features Between COVID-19 and H1N1 Influenza Pneumonia Patients in Zhejiang, China

Distinguishing COVID-19 From Influenza Pneumonia in the Early Stage Through CT Imaging and Clinical Features

Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia

Differential Diagnosis of COVID-19 Pneumonia From Influenza A (H1N1) Pneumonia Using a Model Based on Clinicoradiologic Features

Differentiation of COVID‐19 from Seasonal Influenza: A Multicenter Comparative Study

Value Of High-Resolution Computed Tomography in the Differential Diagnosis of Imported COVID-19 and Seasonal Influenza Pneumonia: Differential Diagnosis of COVID-19 and Influenza Pneumonia using HRCT

Differential Diagnosis Between the Coronavirus Disease 2019 and Streptococcus Pneumoniae Pneumonia by Thin-Slice CT Features

Differential Diagnosis of Coronavirus Disease 2019 from Community-Acquired-pneumonia by Computed Tomography Scan and Follow-Up

Clinical and Computed Tomographic (CT) Images Characteristics in the Patients with COVID-19 Infection: What Should Radiologists Need to Know?

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 with Negative Nucleic Acid Results.

Comparison of Initial High-Resolution Computed Tomography (HRCT) Features of Coronavirus Disease 2019 (COVID-19) Pneumonia and Other Viral Pneumonias.

Comparison of Clinical, Laboratory, and Radiological Characteristics Between SARS-CoV-2 Infection and Community-Acquired Pneumonia Caused by Influenza Virus

Clinical Utility of a Computed Tomography-Based Receiver Operating Characteristic Curve Model for the Diagnosis of COVID-19.

HRCT Features of COVID-19 Patients Admitted out of Wuhan: Comparison against Common Pneumonia

Quantitative CT Imaging Features for COVID-19 Evaluation: the Ability to Differentiate COVID-19 from Non- COVID-19 (highly Suspected) Pneumonia Patients During the Epidemic Period

Comparison of initial thin-section CT features in coronavirus disease 2019 pneumonia and other community-acquired pneumonia

The Clinical Value of Thin-section Chest Computed Tomography Scan for the Classification of Coronavirus Disease 2019(COVID-19)

Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China.

How to Differentiate COVID-19 Pneumonia from Heart Failure with Computed Tomography at Initial Medical Contact During Epidemic Period